# Prestige Consumer Healthcare Inc.: filings

PBH · NYSE · CIK 1295947 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/pbh.md) · [Financials](/companies/pbh/financials.md) · [Filings](/companies/pbh/filings.md) · [Insiders](/companies/pbh/insiders.md)

## Reports and events: 254 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 486, 8-K 156, SC 13G/A 69, 10-Q 53, 144 32, 3 29, 10-K 18, DEF 14A 18, UPLOAD 14, 4/A 13, CORRESP 11, ARS 10, SC 13G 10, 8-K/A 9, SC TO-C 8, SC14D9C 6, SCHEDULE 13G/A 6, DEFA14A 5, DFAN14A 4, 424B3 3, CT ORDER 3, EFFECT 3, S-4 3, SCHEDULE 13G 3, S-8 2, S-8 POS 2, SEC STAFF LETTER 2, 11-K 1, 3/A 1, 8-A12B 1, CERTNYS 1, PRE 14A 1, PREC14A 1, S-4/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-14 | 16:03 ET | [8-K](/filings/0001295947-26-000049.md) | 5.02 Departure or appointment of officers or directors | 0001295947-26-000049 |
| 2026-08-06 | 06:15 ET | [10-Q](/filings/0001295947-26-000042.md) | Quarterly report, period 2026-06-30 | 0001295947-26-000042 |
| 2026-08-06 | 06:04 ET | [8-K](/filings/0001295947-26-000040.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-26-000040 |
| 2026-07-15 | 16:03 ET | [8-K](/filings/0001104659-26-083872.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-083872 |
| 2026-07-09 | 16:43 ET | [8-K/A](/filings/0001295947-26-000032.md) | 9.01 Financial statements and exhibits | 0001295947-26-000032 |
| 2026-07-06 | 08:05 ET | [8-K](/filings/0001295947-26-000029.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-26-000029 |
| 2026-06-30 | 06:01 ET | [8-K/A](/filings/0001295947-26-000025.md) | 9.01 Financial statements and exhibits | 0001295947-26-000025 |
| 2026-06-29 | 06:06 ET | [DEF 14A](/filings/0001295947-26-000021.md) | Proxy statement, period 2026-06-29 | 0001295947-26-000021 |
| 2026-06-16 | 06:15 ET | [8-K](/filings/0001104659-26-074259.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-074259 |
| 2026-05-14 | 16:32 ET | [10-K](/filings/0001295947-26-000016.md) | Annual report, period 2026-03-31 | 0001295947-26-000016 |
| 2026-05-13 | 16:35 ET | [8-K](/filings/0001295947-26-000013.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-26-000013 |
| 2026-03-20 | 06:15 ET | [8-K](/filings/0001104659-26-032332.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-032332 |
| 2026-02-05 | 06:09 ET | [10-Q](/filings/0001295947-26-000008.md) | Quarterly report, period 2025-12-31 | 0001295947-26-000008 |
| 2026-02-05 | 06:04 ET | [8-K](/filings/0001295947-26-000006.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-26-000006 |
| 2025-11-06 | 06:11 ET | [10-Q](/filings/0001295947-25-000039.md) | Quarterly report, period 2025-09-30 | 0001295947-25-000039 |
| 2025-11-06 | 06:03 ET | [8-K](/filings/0001295947-25-000037.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-25-000037 |
| 2025-08-07 | 06:15 ET | [10-Q](/filings/0001295947-25-000029.md) | Quarterly report, period 2025-06-30 | 0001295947-25-000029 |
| 2025-08-07 | 06:07 ET | [8-K](/filings/0001295947-25-000027.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-25-000027 |
| 2025-06-27 | 16:04 ET | [DEF 14A](/filings/0001295947-25-000021.md) | Proxy statement, period 2025-08-05 | 0001295947-25-000021 |
| 2025-05-09 | 06:06 ET | [10-K](/filings/0001295947-25-000017.md) | Annual report, period 2025-03-31 | 0001295947-25-000017 |
| 2025-05-08 | 06:04 ET | [8-K](/filings/0001295947-25-000014.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-25-000014 |
| 2025-02-06 | 06:08 ET | [10-Q](/filings/0001295947-25-000009.md) | Quarterly report, period 2024-12-31 | 0001295947-25-000009 |
| 2025-02-06 | 06:03 ET | [8-K](/filings/0001295947-25-000007.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-25-000007 |
| 2025-01-06 | 08:00 ET | [8-K](/filings/0001104659-25-001076.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-001076 |
| 2024-11-07 | 06:11 ET | [10-Q](/filings/0001295947-24-000032.md) | Quarterly report, period 2024-09-30 | 0001295947-24-000032 |
| 2024-11-07 | 06:03 ET | [8-K](/filings/0001295947-24-000030.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-24-000030 |
| 2024-08-08 | 06:10 ET | [10-Q](/filings/0001295947-24-000025.md) | Quarterly report, period 2024-06-30 | 0001295947-24-000025 |
| 2024-08-08 | 06:03 ET | [8-K](/filings/0001295947-24-000023.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-24-000023 |
| 2024-07-05 | 12:00 ET | [DEF 14A](/filings/0001104659-24-078025.md) | Proxy statement, period 2024-08-06 | 0001104659-24-078025 |
| 2024-05-15 | 07:01 ET | [10-K](/filings/0001295947-24-000017.md) | Annual report, period 2024-03-31 | 0001295947-24-000017 |
| 2024-05-14 | 17:04 ET | [8-K](/filings/0001295947-24-000015.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001295947-24-000015 |
| 2024-05-08 | 17:08 ET | [8-K](/filings/0001104659-24-058841.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-058841 |
| 2024-02-08 | 06:10 ET | [10-Q](/filings/0001295947-24-000008.md) | Quarterly report, period 2023-12-31 | 0001295947-24-000008 |
| 2024-02-08 | 06:05 ET | [8-K](/filings/0001295947-24-000006.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-24-000006 |
| 2023-12-13 | 16:01 ET | [8-K](/filings/0001104659-23-125696.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-23-125696 |
| 2023-11-02 | 06:11 ET | [10-Q](/filings/0001295947-23-000034.md) | Quarterly report, period 2023-09-30 | 0001295947-23-000034 |
| 2023-11-02 | 06:06 ET | [8-K](/filings/0001295947-23-000032.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-23-000032 |
| 2023-08-03 | 06:27 ET | [10-Q](/filings/0001295947-23-000026.md) | Quarterly report, period 2023-06-30 | 0001295947-23-000026 |
| 2023-08-03 | 06:15 ET | [8-K](/filings/0001295947-23-000024.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-23-000024 |
| 2023-06-29 | 16:05 ET | [DEF 14A](/filings/0001104659-23-076310.md) | Proxy statement, period 2023-08-01 | 0001104659-23-076310 |
| 2023-05-05 | 16:08 ET | [10-K](/filings/0001295947-23-000017.md) | Annual report, period 2023-03-31 | 0001295947-23-000017 |
| 2023-05-04 | 06:04 ET | [8-K](/filings/0001295947-23-000014.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001295947-23-000014 |
| 2023-02-02 | 06:11 ET | [10-Q](/filings/0001295947-23-000009.md) | Quarterly report, period 2022-12-31 | 0001295947-23-000009 |
| 2023-02-02 | 06:05 ET | [8-K](/filings/0001295947-23-000006.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-23-000006 |
| 2022-11-03 | 06:37 ET | [10-Q](/filings/0001295947-22-000032.md) | Quarterly report, period 2022-09-30 | 0001295947-22-000032 |
| 2022-11-03 | 06:24 ET | [8-K](/filings/0001295947-22-000030.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-22-000030 |
| 2022-08-04 | 06:17 ET | [10-Q](/filings/0001295947-22-000023.md) | Quarterly report, period 2022-06-30 | 0001295947-22-000023 |
| 2022-08-04 | 06:06 ET | [8-K](/filings/0001295947-22-000020.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001295947-22-000020 |
| 2022-06-28 | 16:01 ET | [DEF 14A](/filings/0001104659-22-075219.md) | Proxy statement, period 2022-08-02 | 0001104659-22-075219 |
| 2022-05-06 | 16:20 ET | [10-K](/filings/0001295947-22-000015.md) | Annual report, period 2022-03-31 | 0001295947-22-000015 |

Page 1 of 6. [Older](/companies/pbh/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.